Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial

[1]  M. Weissman,et al.  Pretreatment Rostral Anterior Cingulate Cortex Theta Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial , 2018, JAMA psychiatry.

[2]  M. Weissman,et al.  Test-retest reliability of cerebral blood flow in healthy individuals using arterial spin labeling: Findings from the EMBARC study. , 2018, Magnetic resonance imaging.

[3]  Simon B Eickhoff,et al.  Identification of Common Neural Circuit Disruptions in Cognitive Control Across Psychiatric Disorders. , 2017, The American journal of psychiatry.

[4]  R. Todd Ogden,et al.  Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study , 2017, Contemporary clinical trials communications.

[5]  C. Zhuo,et al.  Pseudo-continuous arterial spin labeling imaging of cerebral blood perfusion asymmetry in drug-naïve patients with first-episode major depression , 2016, Biomedical reports.

[6]  A. Abi-Dargham,et al.  The search for imaging biomarkers in psychiatric disorders , 2016, Nature Medicine.

[7]  Y. Okamoto,et al.  Changes in the regional cerebral blood flow detected by arterial spin labeling after 6-week escitalopram treatment for major depressive disorder. , 2016, Journal of affective disorders.

[8]  H. Kraemer,et al.  Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design. , 2016, Journal of psychiatric research.

[9]  M. Trivedi,et al.  Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. , 2015, The American journal of psychiatry.

[10]  Simon Schwab,et al.  Functional connectivity in BOLD and CBF data: Similarity and reliability of resting brain networks , 2015, NeuroImage.

[11]  G. Zaharchuk,et al.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. , 2015, Magnetic resonance in medicine.

[12]  M. Ota,et al.  Characteristic distributions of regional cerebral blood flow changes in major depressive disorder patients: a pseudo-continuous arterial spin labeling (pCASL) study. , 2014, Journal of affective disorders.

[13]  Richard A. Berk,et al.  Inference for Treatment Regime Models in Personalized Medicine , 2014 .

[14]  G. Glover,et al.  Causal interactions between fronto-parietal central executive and default-mode networks in humans , 2013, Proceedings of the National Academy of Sciences.

[15]  Karl J. Friston,et al.  Anterior insular cortex and emotional awareness , 2013, The Journal of comparative neurology.

[16]  D. Kupfer,et al.  Pattern recognition analysis of anterior cingulate cortex blood flow to classify depression polarity† , 2013, British Journal of Psychiatry.

[17]  M. Dubin,et al.  Prefrontal cortical blood flow predicts response of depression to rTMS. , 2013, Journal of affective disorders.

[18]  M. Trivedi.  Modeling Predictors, Moderators and Mediators of Treatment Outcome and Resistance in Depression , 2013, Biological Psychiatry.

[19]  Helena Chmura Kraemer,et al.  Discovering, comparing, and combining moderators of treatment on outcome after randomized clinical trials: a parametric approach , 2013, Statistics in medicine.

[20]  J. Detre,et al.  Quantification of Cerebral Blood Flow as Biomarker of Drug Effect: Arterial Spin Labeling phMRI After a Single Dose of Oral Citalopram , 2011, Clinical pharmacology and therapeutics.

[21]  M. Frank,et al.  From reinforcement learning models to psychiatric and neurological disorders , 2011, Nature Neuroscience.

[22]  Sina Aslan,et al.  On the sensitivity of ASL MRI in detecting regional differences in cerebral blood flow. , 2010, Magnetic resonance imaging.

[23]  P. Jannin,et al.  Chronic and treatment-resistant depression: A study using arterial spin labeling perfusion MRI at 3Tesla , 2010, Psychiatry Research: Neuroimaging.

[24]  Laura M Parkes,et al.  Depressive Disorders : Focally Altered Cerebral Perfusion Measured with Arterial Spin-labeling MR Imaging 1 , 2009 .

[25]  Eric J. Nestler,et al.  The molecular neurobiology of depression , 2008, Nature.

[26]  Brian Knutson,et al.  Neural Responses to Monetary Incentives in Major Depression , 2008, Biological Psychiatry.

[27]  M. Fava,et al.  Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*D , 2008, Journal of General Internal Medicine.

[28]  W. Alexander.  American psychiatric association. , 2008, P & T : a peer-reviewed journal for formulary management.

[29]  C. Halldin,et al.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.

[30]  H. Mayberg.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. , 2003, British medical bulletin.

[31]  A. Barnes,et al.  Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression. , 2003, The American journal of psychiatry.

[32]  H. Kraemer,et al.  Mediators and moderators of treatment effects in randomized clinical trials. , 2002, Archives of general psychiatry.

[33]  R. Gur,et al.  Neuroscience research agenda to guide development of a pathophysiologically based classification system. , 2002 .

[34]  L. Parsons,et al.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.